Physician Champion for Neurology Startup

Physician Champion – Advisory Board Neurogenesis | United States (Remote)

About Neurogenesis Neurogenesis is a clinical-stage biotechnology company developing NG01, an autologous bone marrow–derived cell therapy designed to promote remyelination and neurological repair in Progressive Multiple Sclerosis (MS).

Over 120 patients have been treated across multiple clinical trials, including randomized, placebo-controlled studies. NG01 has demonstrated safety and signals of functional improvement.

Backed by institutional investors, Neurogenesis is advancing toward Phase 3 readiness and global commercialization with the mission of redefining what is possible in neurodegenerative disease.

Role Overview We are seeking Physician Champions across specialties who are passionate about advancing innovation in neurodegenerative disease and regenerative medicine. This is a flexible advisory role requiring approximately 1–2 hours per month. It is designed for practicing physicians who want to support groundbreaking therapeutic innovation while maintaining their primary clinical or academic commitments.

Advisory Contributions • Serve as a clinical advocate and external champion for the company • Provide high-level perspective on real-world care delivery and patient impact • Offer strategic input on long-term growth and market adoption • Support awareness-building within professional networks • Make selective introductions to key stakeholders when appropriate

Ideal Background • Board-certified Physician (any specialty) • Interest in neurodegenerative disease, regenerative medicine, or breakthrough therapeutics • Thoughtful, strategic mindset with enthusiasm for innovation • Strong professional network within healthcare

Why Join • Help shape a potential first-in-class neurorepair therapy • Engage directly with an experienced biotech leadership team • Option to invest alongside institutional backers • Remote, flexible commitment (1–2 hours per month)

If you are interested in championing transformative innovation in medicine, we welcome a conversation.